DURECT Corp (DRRX.OQ)

DRRX.OQ on NASDAQ Stock Exchange Global Market

1.26USD
1 Aug 2013
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.26
Open
$1.25
Day's High
$1.29
Day's Low
$1.24
Volume
9,453
Avg. Vol
123,188
52-wk High
$1.85
52-wk Low
$0.61

DRRX.OQ

Chart for DRRX.OQ

About

Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development, with one program the subject of a New... (more)

Overall

Beta: 1.28
Market Cap (Mil.): $128.39
Shares Outstanding (Mil.): 101.89
Dividend: --
Yield (%): --

Financials

  DRRX.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.22 -- --
ROI: -53.40 -2.58 18.76
ROE: -57.01 -2.66 19.59
Search Stocks

Pain Therapeutics, Durect shares soar on Pfizer's Remoxy comments

- Shares of Pain Therapeutics Inc and Durect Corp rose more than 40 percent after partner Pfizer Inc said it is in talks with U.S. health regulators to find a way forward on the companies' painkiller, Remoxy.

30 Apr 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$58.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks